Now showing items 1-2 of 2

  • Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non-hypertensive Alzheimer’s patients 

    Al-Hamed, ‪Faez Saleh; Kouniaris, Stamatis; Tamimi, Iskandar; Lordkipanidzé, Marie; Madathi, Sreenath Arekunnath; Kezouh, Abbas; Karp, Igor; Nicolau, Belinda; Tamimi, Faleh (2021-08-20)
    Introduction: Acetylcholinesterase inhibitors (AChEIs) are commonly used to treat mild to moderate cases of Alzheimer disease (AD). To the best of our knowledge, there has been no study estimating the risk of bleeding and cardiovascular events in ...
  • Tyrosine-based rivastigmine-loaded organogels in the treatmant of Alzheimer's disease 

    Bastiat, Guillaume; Plourde, François; Motulsky, Aude; Furtos, Alexandra; Dumont, Yvan; Quirion, Rémi; Fuhrmann, Gregor; Leroux, Jean-Christophe (2010-08)
    Organogels can be prepared by immobilizing an organic phase into a threedimensional network coming from the self-assembly of a low molecular weight gelator molecule. In this work, an injectable subcutaneous organogel system based on safflower oil and ...